Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions

Loss-of-control EatingObesity/Overweight

Interventions

DRUG

Lisdexamfetamine Dimesylate (Medication)

Medication will be taken daily in pill form.

OTHER

Placebo

Placebo will be inactive and taken daily in pill form.

Trial Locations (1)

Yale School of Medicine, New Haven

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER